|
21 Dec 2019 |
Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer
|
|
20 Dec 2019 |
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
|
|
20 Dec 2019 |
GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
|
|
20 Dec 2019 |
Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
|
|
20 Dec 2019 |
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease
|
|
20 Dec 2019 |
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
|
|
20 Dec 2019 |
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma
|
|
20 Dec 2019 |
PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S.
|
|
20 Dec 2019 |
Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism
|
|
19 Dec 2019 |
Turnstone Biologics Announces Global Collaboration and License Agreement with Takeda to Develop Novel Viral Immunotherapies
|
|
19 Dec 2019 |
Oxurion NV to Focus Clinical Development on Molecules Targeting VEGF Independent Pathways for Treatment of DME
|
|
19 Dec 2019 |
Ionis licenses investigational Alzheimer's therapy
|
|
18 Dec 2019 |
Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers
|
|
18 Dec 2019 |
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody
|
|
18 Dec 2019 |
Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders
|
|
11 Dec 2019 |
GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery
|
|
10 Dec 2019 |
AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics
|
|
09 Dec 2019 |
Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
|
|
09 Dec 2019 |
Merck to Acquire ArQule, Advancing Leadership in Oncology
|
|
09 Dec 2019 |
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
|
|
09 Dec 2019 |
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
|
|
08 Dec 2019 |
Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals
|
|
08 Dec 2019 |
Janssen to Acquire Investigational Bermekimab from XBiotech
|
|
06 Dec 2019 |
Cerecor to Acquire Aevi Genomic Medicine
|
|
04 Dec 2019 |
Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery
|
